DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on November 9, 2005; DOI: 10.1124/dmd.105.005280


0090-9556/06/3402-296-304$20.00
DMD 34:296-304, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.005280v1
34/2/296    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yang, J.-H.
Right arrow Articles by Chung, J.-G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, J.-H.
Right arrow Articles by Chung, J.-G.

INHIBITION OF LUNG CANCER CELL GROWTH BY QUERCETIN GLUCURONIDES VIA G2/M ARREST AND INDUCTION OF APOPTOSIS

Jen-Hung Yang, Te-Chun Hsia, Hsiu-Maan Kuo, Pei-Dawn Lee Chao, Chi-Chung Chou, Yau-Huei Wei, and Jing-Gung Chung

Department of Dermatology (J.-H.Y.), Chung Shan Medical University Hospital, Taichung, Taiwan; Department of Internal Medicine (T.-C.H.), China Medical University Hospital, Taichung, Taiwan; Departments of Parasitology (H.-M.K.) and Pharmacy (P.-D.L.C.), China Medical University, Taichung, Taiwan; Department of Veterinary Medicine (C.-C.C.), National Chung-Hsin University, Taichung, Taiwan; Department of Biochemistry (Y.H.-W.), National Yang-Ming University, Taipei, Taiwan; and School of Biological Science and Technology (J.-G.C.), China Medical University, Taichung, Taiwan, Republic of China

Lung cancer is the leading cause of cancer death in many developed countries, including Taiwan. Quercetin, a widely distributed bioflavonoid, is well known to induce growth inhibition in a variety of human cancer cells. Quercetin glucuronides are the main circulating metabolites after dietary supplements with quercetin in humans. However, there is little information available as to how quercetin glucuronides affect human cancer cells. We investigated the effects of quercetin glucuronides in a human lung cancer cell line NCI-H209. We checked the cell viability, cell cycle checkpoint proteins, pro- and antiapoptotic proteins, caspase-3 activity, and gene expression by flow cytometry and Western blot. The viability of cells decreased in a dose- and time-dependent manner. Cell cycle analysis revealed a significant increase of the proportion of cells in G2/M phase and subG0/G1 phase (corresponding to apoptotic cells). Moreover, quercetin glucuronides increased the expressions of cyclin B, Cdc25c-ser-216-p, and Wee1 proteins, indicating the G2/M arrest. We also demonstrated a concurrent decrease of the mitochondrial membrane potential, release of cytochrome c, up-regulation of Bax, down-regulation of Bcl-2, and activation of caspase-3, and subsequently, cleavage of poly(ADP-ribose) polymerase. In addition, quercetin glucuronide-induced apoptosis was totally blocked by the broad-spectrum caspase inhibitor benzyloxycarbonyl-Val-Ala-Asp fluoromethylketone. Taken together, we demonstrated that quercetin glucuronides inhibited proliferation through G2/M arrest of the cell cycle and induced apoptosis via caspase-3 cascade in the human lung cancer cell line NCI-H209. Delineation of the biological effects of specific major quercetin metabolites on chemotherapeutic potential or chemoprevention of human cancers warrants further investigation.


Address correspondence to: Dr. Jing-Gung Chung, Department of Microbiology, China Medical University, No 91, Hsueh-Shih Road, Taichung 404, Taiwan, Republic of China. E-mail: jgchung{at}mail.cmu.edu.tw




This article has been cited by other articles:


Home page
BloodHome page
F.-T. Liu, S. G. Agrawal, Z. Movasaghi, P. B. Wyatt, I. U. Rehman, J. G. Gribben, A. C. Newland, and L. Jia
Dietary flavonoids inhibit the anticancer effects of the proteasome inhibitor bortezomib
Blood, November 1, 2008; 112(9): 3835 - 3846.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. D. Stoner, L.-S. Wang, and B. C. Casto
Laboratory and clinical studies of cancer chemoprevention by antioxidants in berries
Carcinogenesis, September 1, 2008; 29(9): 1665 - 1674.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.